BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda

Monday, December 18, 2023 1 min read

Key Takeaway: BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda